Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (431-440 of 681) with videos related to

Pageof 69
Sort By:
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Clinical and Experimental Immunology|November 25, 2000
Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternallyC Ostergaard, R V Yieng-Kow, C G Larsen, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
AIDS (London, England)|October 23, 2020
Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohortsBrad T Sherman, Xiaojun Hu, Kanal Singh, et al.
HIV Medicine|May 20, 2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA studyD Podlekareva, D Grint, I Karpov, et al.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
Pageof 69

Showing results (431-440 of 681) with videos related to

Sort By:
Pageof 69
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Clinical and Experimental Immunology|November 25, 2000
Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternallyC Ostergaard, R V Yieng-Kow, C G Larsen, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
AIDS (London, England)|October 23, 2020
Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohortsBrad T Sherman, Xiaojun Hu, Kanal Singh, et al.
HIV Medicine|May 20, 2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA studyD Podlekareva, D Grint, I Karpov, et al.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
Pageof 69